Tag Archives: Biotech Investment

Opaleye Management Inc. buys $193k worth of Codexis stock, a move that sends ripples through the biotech and enzyme engineering sectors. This strategic investment, a significant bet on Codexis’s future, raises questions about Opaleye’s motivations and the potential impact on the biotech landscape. The investment, a testament to Opaleye’s keen …

Read More »